Antibodies directed to parathyroid hormone (pth) and uses thereof
CA 2535156 A1 · Owner: Roskos, Lorin · Inventors: Roskos, Lorin; King, Chadwick T.; Foltz, Ian
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Embodiments of the invention described herein relate to antibodies directed to the antigen parathyroid hormone (PTH) and uses of such antibodies. In particular, in some embodiments, there are provided fully human monoclonal antibodies directed to the antigen PTH. In further embodiments nucleotide , sequences encoding, and amino acid sequences comprising heavy and light chain , immunoglobulin molecules particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDRs) specifically from FR1 through FR4 , or CDR1 through CDR3 are provided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 8, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 8, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 8, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.